{"entity": "researcher", "timestamp": "2026-08-18T04:39:02.753Z", "family": "Glimelius", "given": "Ingrid", "initials": "I", "orcid": "0000-0001-6158-3041", "affiliations": ["Department of Immunology, Genetics and Pathology, Cancer Precision Medicine, Uppsala University, Sweden."], "links": {"self": {"href": "https://publications.scilifelab.se/researcher/3db3caec5bef41d2b92cb8e3cf8221ea.json"}, "display": {"href": "https://publications.scilifelab.se/researcher/3db3caec5bef41d2b92cb8e3cf8221ea"}}, "publications": [{"entity": "publication", "iuid": "b06f085f37b44c15b8272cfc0be931c0", "links": {"self": {"href": "https://publications.scilifelab.se/publication/b06f085f37b44c15b8272cfc0be931c0.json"}, "display": {"href": "https://publications.scilifelab.se/publication/b06f085f37b44c15b8272cfc0be931c0"}}, "title": "Accumulation of high-risk genetic features after chemoimmunotherapy: A longitudinal study in mantle cell lymphoma.", "authors": [{"family": "Nikkarinen", "given": "Anna", "initials": "A", "orcid": "0009-0001-1451-0699", "researcher": {"href": "https://publications.scilifelab.se/researcher/94d8ab03b76a48658bed5af695014e83.json"}}, {"family": "Alml\u00f6f", "given": "Jonas", "initials": "J"}, {"family": "\u00d6sterroos", "given": "Albin", "initials": "A", "orcid": "0000-0001-8749-7299", "researcher": {"href": "https://publications.scilifelab.se/researcher/47a3ea9e722b4c72a7f00a61b5c9fe0a.json"}}, {"family": "Ladenvall", "given": "Claes", "initials": "C", "orcid": "0000-0002-7501-6598", "researcher": {"href": "https://publications.scilifelab.se/researcher/4c5c362dc308476195eb55d2e588ba60.json"}}, {"family": "Amini", "given": "Rose-Marie", "initials": "RM", "orcid": "0000-0003-0901-5252", "researcher": {"href": "https://publications.scilifelab.se/researcher/c157abcd61fa4900b5ad502b408d6d95.json"}}, {"family": "Hollander", "given": "Peter", "initials": "P", "orcid": "0000-0002-0226-5681", "researcher": {"href": "https://publications.scilifelab.se/researcher/b1c6693d3ede463eb78e6da010db601f.json"}}, {"family": "Ayoola Gustafsson", "given": "Kristin", "initials": "K"}, {"family": "Baliakas", "given": "Panagiotis", "initials": "P", "orcid": "0000-0002-5634-7156", "researcher": {"href": "https://publications.scilifelab.se/researcher/17370bd509dc4b1081af5aed9e5117c7.json"}}, {"family": "Glimelius", "given": "Ingrid", "initials": "I", "orcid": "0000-0001-6158-3041", "researcher": {"href": "https://publications.scilifelab.se/researcher/3db3caec5bef41d2b92cb8e3cf8221ea.json"}}], "type": "letter", "published": "2026-03-00", "journal": {"title": "Leukemia", "issn": "1476-5551", "volume": "40", "issue": "3", "pages": "681-684", "issn-l": "0887-6924"}, "abstract": null, "doi": "10.1038/s41375-026-02861-1", "pmid": "41639203", "labels": {"Clinical Genomics": "Collaborative", "Clinical Genomics Uppsala": "Collaborative"}, "xrefs": [{"db": "pii", "key": "10.1038/s41375-026-02861-1"}], "notes": [], "created": "2026-08-07T07:54:48.200Z", "modified": "2026-08-07T07:54:48.321Z"}, {"entity": "publication", "iuid": "9afbaeee322443f5b2209c9afa15ffc4", "links": {"self": {"href": "https://publications.scilifelab.se/publication/9afbaeee322443f5b2209c9afa15ffc4.json"}, "display": {"href": "https://publications.scilifelab.se/publication/9afbaeee322443f5b2209c9afa15ffc4"}}, "title": "Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2.", "authors": [{"family": "Ginman", "given": "Beatrice", "initials": "B"}, {"family": "Pahnke", "given": "Simon", "initials": "S", "orcid": "0000-0002-3541-2027", "researcher": {"href": "https://publications.scilifelab.se/researcher/0040221ec27a44c4b05b7e886cd48bbb.json"}}, {"family": "Freyhult", "given": "Eva", "initials": "E"}, {"family": "Hoffman", "given": "Tove", "initials": "T"}, {"family": "Kolstad", "given": "Linda", "initials": "L"}, {"family": "R\u00f6nnberg", "given": "Bengt", "initials": "B"}, {"family": "Lundkvist", "given": "\u00c5ke", "initials": "\u00c5"}, {"family": "Hamberg Levedahl", "given": "Kerstin", "initials": "K"}, {"family": "Enblad", "given": "Gunilla", "initials": "G"}, {"family": "Glimelius", "given": "Ingrid", "initials": "I", "orcid": "0000-0001-6158-3041", "researcher": {"href": "https://publications.scilifelab.se/researcher/3db3caec5bef41d2b92cb8e3cf8221ea.json"}}], "type": "journal article", "published": "2023-09-20", "journal": {"title": "Acta Oncol", "issn": "1651-226X", "pages": "1-9", "issn-l": "0284-186X"}, "abstract": "Background: Swedish recommendations to reduce the risk of COVID-19 relied on each citizen's own sense of responsibility rather than mandatory lockdowns. We studied how COVID-19-related self-isolation and anxiety correlated to SARS-CoV-2 seropositivity and PCR-positivity in patients with active cancer treatment.Methods: In a longitudinal cohort study at Uppsala University Hospital patients and cancer personnel were included between April 1st 2020 to August 1st 2020. Serological testing for SARS-CoV-2 was done every 8-12-weeks until 30 March 2021. Patients completed a survey at inclusion regarding self-reported COVID-19-related anxiety and self-isolation.Results: A total of 622 patients [n = 475 with solid malignancies (SM), n = 147 with haematological malignancies (HM)], and 358 healthcare personnel were included. The seropositivity rate was lower for patients than for personnel; 10.5% for SM patients, 6.8% for HM patients, and 16.2% for personnel (p = 0.005). Strict adherence to self-isolation guidelines was reported by 54% of patients but was not associated with a lower risk of becoming seropositive [OR = 1.4 (0.8-2.5), p = 0.2]. High anxiety was expressed by 32% of patients, more often by SM patients than HM patients (34% vs 25% [OR = 1.6 (1.1-2.5, p = 0.03)]). Female gender [OR = 3.5 (2.4-5.2), p < 0.001] and being born outside of Europe [OR = 2.9 (1.4-6.4), p = 0.007] were both associated with high anxiety. Patients reporting high anxiety became seropositive to a similar degree as those with low anxiety [OR = 0.7 (0.3-1.2), p = 0.2]. HM patients with PCR-positive COVID-19 were more likely than SM patients to require oxygen therapy, including non-invasive ventilation/intubation (69% vs. 26%, p = 0.005).Conclusion: For Swedish patients on active cancer treatment, high self-assessed COVID-19-related anxiety or strict adherence to self-isolation guidelines were not associated with a lower risk of COVID-19. Patients with HM were less likely to develop serological antibody response after COVID-19 and were more likely to require advanced hospital care, but expressed less COVID-19-related anxiety than patients with SM.", "doi": "10.1080/0284186X.2023.2257873", "pmid": "37729083", "labels": {"Bioinformatics Support and Infrastructure": "Collaborative", "Bioinformatics Support, Infrastructure and Training": "Collaborative", "Bioinformatics (NBIS)": "Collaborative"}, "xrefs": [], "notes": [], "created": "2023-11-16T12:20:43.626Z", "modified": "2023-11-16T12:20:43.691Z"}]}